Further research is needed to elucidate the specific mechanisms and functions of IL-22 in regulating the pulmonary microenvironment and its involvement in pro-inflammatory processes before it may be used as a new immunotherapeutic strategy for COVID-19. Here, IL22 is linked to COVID-19.